Search research articles
Contact Us
Filters
Showing results (271-280 of 291) with videos related to
Page
of 30
Sort By:
Alimentary Pharmacology & Therapeutics
|
January 26, 2013
Stool DNA testing for the detection of colorectal neoplasia in patients with inflammatory bowel disease
J B Kisiel, T C Yab, F T Nazer Hussain, et al.
Blood Advances
|
September 28, 2021
Impact of cryopreservation and transit times of allogeneic grafts on hematopoietic and immune reconstitution
Katie Maurer, Haesook T Kim, Thomas M Kuczmarski, et al.
Omics : a Journal of Integrative Biology
|
June 21, 2008
Meeting report: the fourth Genomic Standards Consortium (GSC) workshop
Dawn Field, Frank Oliver Glöckner, George M Garrity, et al.
Hepatology (Baltimore, Md.)
|
August 21, 2010
The oncogenic effect of sulfatase 2 in human hepatocellular carcinoma is mediated in part by glypican 3-dependent Wnt activation
Jin-Ping Lai, Abdul M Oseini, Catherine D Moser, et al.
JACC. Basic to Translational Science
|
December 24, 2016
<i>FLNC</i> Gene Splice Mutations Cause Dilated Cardiomyopathy
Rene L Begay, Charles A Tharp, August Martin, et al.
Omics : a Journal of Integrative Biology
|
June 21, 2008
Meeting report: the fifth Genomic Standards Consortium (GSC) workshop
Dawn Field, George M Garrity, Susanna-Assunta Sansone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 2004
Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group Study
Megan M Garrity, Lawrence J Burgart, Michelle R Mahoney, et al.
Hepatology (Baltimore, Md.)
|
March 6, 2008
Sulfatase 2 up-regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma
Jin-Ping Lai, Dalbir S Sandhu, Chunrong Yu, et al.
Blood Advances
|
May 15, 2024
Active infection at the time of CD34+ selected stem cell boost is associated with treatment failure and poor overall survival
Roman M Shapiro, Haesook T Kim, Remy Dulery, et al.
The Journal of Antibiotics
|
March 1, 1996
Quinoxapeptins: novel chromodepsipeptide inhibitors of HIV-1 and HIV-2 reverse transcriptase. I. The producing organism and biological activity
R B Lingham, A H Hsu, J A O'Brien, et al.
Page
of 30
Search research articles
Search
Showing results (271-280 of 291) with videos related to
Sort By:
Page
of 30
Alimentary Pharmacology & Therapeutics
|
January 26, 2013
Stool DNA testing for the detection of colorectal neoplasia in patients with inflammatory bowel disease
J B Kisiel, T C Yab, F T Nazer Hussain, et al.
Blood Advances
|
September 28, 2021
Impact of cryopreservation and transit times of allogeneic grafts on hematopoietic and immune reconstitution
Katie Maurer, Haesook T Kim, Thomas M Kuczmarski, et al.
Omics : a Journal of Integrative Biology
|
June 21, 2008
Meeting report: the fourth Genomic Standards Consortium (GSC) workshop
Dawn Field, Frank Oliver Glöckner, George M Garrity, et al.
Hepatology (Baltimore, Md.)
|
August 21, 2010
The oncogenic effect of sulfatase 2 in human hepatocellular carcinoma is mediated in part by glypican 3-dependent Wnt activation
Jin-Ping Lai, Abdul M Oseini, Catherine D Moser, et al.
JACC. Basic to Translational Science
|
December 24, 2016
<i>FLNC</i> Gene Splice Mutations Cause Dilated Cardiomyopathy
Rene L Begay, Charles A Tharp, August Martin, et al.
Omics : a Journal of Integrative Biology
|
June 21, 2008
Meeting report: the fifth Genomic Standards Consortium (GSC) workshop
Dawn Field, George M Garrity, Susanna-Assunta Sansone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 2004
Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group Study
Megan M Garrity, Lawrence J Burgart, Michelle R Mahoney, et al.
Hepatology (Baltimore, Md.)
|
March 6, 2008
Sulfatase 2 up-regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma
Jin-Ping Lai, Dalbir S Sandhu, Chunrong Yu, et al.
Blood Advances
|
May 15, 2024
Active infection at the time of CD34+ selected stem cell boost is associated with treatment failure and poor overall survival
Roman M Shapiro, Haesook T Kim, Remy Dulery, et al.
The Journal of Antibiotics
|
March 1, 1996
Quinoxapeptins: novel chromodepsipeptide inhibitors of HIV-1 and HIV-2 reverse transcriptase. I. The producing organism and biological activity
R B Lingham, A H Hsu, J A O'Brien, et al.
Page
of 30